about
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosisIntrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosisSumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylaseEncoding of motor skill in the corticomuscular system of musicians.Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown.Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography.Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.Treating multiple sclerosis with monoclonal antibodies: a 2010 update.Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response.Genome-wide significant association with seven novel multiple sclerosis risk loci.A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.Characteristic gene expression profile of primary human cerebral endothelial cells.Central motor conduction time may predict response to fampridine in patients with multiple sclerosis"Sporadic" familial amyloidotic polyneuropathy in a German patient with B cell lymphocytic leukaemia.Local pain during REBIF injection is not due to acidic pH.[Quadrivalent HPV vaccination does not increase MS risk].Atypical chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS), primary angiitis of the CNS mimicking CLIPPERS or overlap syndrome? A case report.Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis.Can we get rid of neutralizing antibodies against interferon-β?Analysis of the stathmin rs182455 single nucleotide promoter polymorphism in patients with multiple sclerosis.Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis.Oligoclonal bands predict multiple sclerosis in children with optic neuritis.Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.[Therapeutic monoclonal antibodies in clinical neurology].Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.Assessment of microRNA-related SNP effects in the 3′ untranslated region of the IL22RA2 risk locus in multiple sclerosisCBP/p300 Integrates Raf/Rac-Signaling Pathways in the Transcriptional Induction of NF-ATc during T Cell ActivationSUMOylation of the transcription factor NFATc1 leads to its subnuclear relocalization and IL2 repression by HDACNFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanismsHuman Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier BreakdownSubcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine inductionThe PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells
P50
Q28484467-EE8C100A-83E8-4261-B384-A33D484B9DD6Q28727371-57C6B5BB-7D6E-47E9-BABB-60B8C22DB0CEQ30486988-5A702276-539C-49FE-8CC7-95B25601EC07Q30551345-D68651A1-C306-44EF-A60C-5E2AC8DB4F13Q33741764-F25AE2DD-BAFE-43F8-9776-61AB45496E1BQ34088519-9A36CD35-6D34-4779-A6D7-1953D022DC3DQ35179770-FE31FF53-EC4C-4F0D-8E65-87CFB146A1D6Q35512654-5E61E460-940C-478F-8B3A-8308655DAB1FQ36376777-4432BD56-A78A-4FA2-A5A4-694E6C0864FBQ36904914-8A919854-1178-47FC-A9C6-49A49ACB5C37Q37415501-B98E13DF-0A79-4B12-B248-5F9E81B6A70DQ37737305-FFF0470A-053D-4269-8CB8-4F86BF9CFDD9Q38116196-44AC8A34-28F0-4450-9DD2-A6DD7A0DCB5EQ38842649-C0187B29-0F41-4646-8616-859E9A530563Q40172029-A94028C3-71AB-49EF-A855-C58FEAB0933FQ40422665-7C3E6EE2-08D9-425E-9536-09D037D7FA59Q41369774-121D9DC7-76AC-4045-B46E-02B604D86B08Q42505533-3382C17B-644F-4B11-9281-C834A115DBE2Q42519394-A6DBE92F-CFC6-4BBE-ADF9-30EA51E082DCQ42588431-4B753ABD-F189-4AEF-814B-D883AA0CFA90Q43045087-44D8809F-940F-4DAE-9BC6-0754C46A82F1Q43068442-6A01FC43-BE7E-4B91-BD8B-1B22EB43DE0EQ43854399-6CE79745-7172-49F3-8BFA-A835C03081EDQ44581345-15C6FE03-7799-4E81-8F6E-A12E5C436BE0Q45090918-6BFEF98F-45C7-4EF9-8E8B-733855C17657Q46195687-9618FF99-5E02-4B7D-AB3C-A21E8222A47FQ48826368-BF6D2DEF-4B2F-4961-9386-19DFA34A0848Q48939674-30A597D9-01E0-48CE-BE56-243E82CC5F0BQ49127330-8780F0C2-3097-473C-AB88-863F53A4B19CQ50594301-0261E2A8-622C-46D2-9BFC-85430D8ED3B2Q52885249-49F17B02-07E8-4260-B332-6FD380BE1210Q53308501-5629E880-F727-41A3-A3CE-D5510C2C0A42Q54459053-7B05455E-3407-453F-9C1B-83B88EF9B545Q57623481-68DFB49A-16C3-47A8-AE83-2986AE640FC6Q57888734-04B7DF2D-ED9D-49C0-ABCC-4B990324F77BQ59249021-A6202E3A-BAB4-4E33-BB86-E707AC068B79Q60315851-2D8E8E59-9FF4-4EC9-BB81-FD9ABD5D882FQ64277249-DF450165-B222-4CB0-B535-35BC3D5E7784Q81124629-724C2F6D-8856-497C-A454-908CD1690628Q81324038-83A72ADA-3D5F-471C-96C2-6B7F23DAB10F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mathias Buttmann
@ast
Mathias Buttmann
@br
Mathias Buttmann
@co
Mathias Buttmann
@cs
Mathias Buttmann
@da
Mathias Buttmann
@de
Mathias Buttmann
@en
Mathias Buttmann
@es
Mathias Buttmann
@fr
Mathias Buttmann
@id
type
label
Mathias Buttmann
@ast
Mathias Buttmann
@br
Mathias Buttmann
@co
Mathias Buttmann
@cs
Mathias Buttmann
@da
Mathias Buttmann
@de
Mathias Buttmann
@en
Mathias Buttmann
@es
Mathias Buttmann
@fr
Mathias Buttmann
@id
altLabel
M Buttmann
@en
prefLabel
Mathias Buttmann
@ast
Mathias Buttmann
@br
Mathias Buttmann
@co
Mathias Buttmann
@cs
Mathias Buttmann
@da
Mathias Buttmann
@de
Mathias Buttmann
@en
Mathias Buttmann
@es
Mathias Buttmann
@fr
Mathias Buttmann
@id
P214
P106
P21
P214
P31
P496
0000-0001-8309-7685
P7859
viaf-40293687